Business Context and Reporting Period
Company: Archimedes Tech SPAC Partners III Co.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2026
Status: Cayman Islands blank check company (SPAC) formed on August 1, 2025. The company has not commenced operations and is searching for a target business combination in the technology sector.
Key Event: Consummated its Initial Public Offering (IPO) on January 26, 2026, including the full exercise of the underwriters' over-allotment option.
Key Financial Metrics
| Metric | Value (as of/for period ended June 30, 2026) |
|---|---|
| Trust Account Balance | $280,254,125 |
| Cash (Outside Trust) | $1,009,308 |
| Total Assets | $281,499,401 |
| Net Income (Six Months) | $3,862,169 |
| Net Income (Three Months) | $2,288,115 |
| General & Administrative Expenses (Six Months) | $410,310 |
| Interest Income (Trust Account, Six Months) | $4,254,125 |
| Total Liabilities | $9,783,960 |
| Deferred Underwriting Fee | $9,660,000 |
| Ordinary Shares Subject to Redemption | 27,600,000 shares ($10.15/share) |
| Working Capital | $1,053,342 |
Material Changes vs. Prior Period
- Asset Growth: Total assets increased from $182,090 at December 31, 2025, to $281,499,401 at June 30, 2026, driven by the IPO proceeds deposited into the Trust Account.
- Revenue Generation: The company generated no operating revenue. Net income is derived entirely from interest earned on the Trust Account and bank cash balances.
- Equity Structure: Following the IPO, 27,600,000 public shares are classified as temporary equity (subject to redemption), whereas none existed at the prior period end.
- Liabilities: Current liabilities decreased from $226,611 to $123,960 after repaying the related-party promissory note, but total liabilities increased due to the recognition of a $9,660,000 deferred underwriting fee.
Outlook, Risks, and Management Commentary
- Completion Window: The company has 24 months from the IPO closing (January 26, 2026) to complete a Business Combination. If unsuccessful, it will liquidate and redeem public shares.
- Liquidity: Management believes current cash outside the Trust ($1.0 million) is sufficient to fund operations for at least one year. No working capital loans are currently outstanding.
- Redemption Rights: Public shareholders may redeem shares for a pro-rata portion of the Trust Account (approx. $10.15/share as of June 30, 2026) upon a business combination or liquidation.
- Risks: The filing highlights risks associated with early-stage companies, the inability to complete a business combination, and potential dilution from warrant exercises. Geopolitical instability and market downturns are cited as potential impediments to finding a target.
- Related Party Transactions: The company pays the Sponsor $20,000 per month for administrative support. Founder Shares are subject to a lock-up until six months post-combination or until the share price exceeds $12.00.
Investor Verification Checklist
- Trust Account Yield: Verify the interest rate environment and the specific composition of the Trust Account investments (U.S. Treasury obligations vs. money market funds) to assess future income potential.
- Redemption Thresholds: Confirm the specific net tangible asset requirements that might limit the company's ability to complete a deal if a significant number of shareholders redeem.
- Deferred Fees: Note the $9,660,000 deferred underwriting fee payable only upon a successful Business Combination, which reduces the net cash available to the combined entity.
- Warrant Terms: Review the exercise price ($11.50) and redemption triggers ($18.00 share price) for the 7,090,500 outstanding warrants.
- Extension Options: Check the amended and restated memorandum and articles of association for any provisions allowing the Sponsor to extend the 24-month completion window.